7-Hydroxy-2-(4-methoxyphenylimino)-2H-chromene-3-carboxylic acid benzylamide

ID: ALA2440417

PubChem CID: 136219385

Max Phase: Preclinical

Molecular Formula: C24H20N2O4

Molecular Weight: 400.43

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  COc1ccc(/N=c2\oc3cc(O)ccc3cc2C(=O)NCc2ccccc2)cc1

Standard InChI:  InChI=1S/C24H20N2O4/c1-29-20-11-8-18(9-12-20)26-24-21(13-17-7-10-19(27)14-22(17)30-24)23(28)25-15-16-5-3-2-4-6-16/h2-14,27H,15H2,1H3,(H,25,28)/b26-24-

Standard InChI Key:  QEQGIVVMPNNCOY-LCUIJRPUSA-N

Molfile:  

     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
   11.6335   -6.2440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6335   -5.4268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9285   -5.0182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2194   -5.4268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5104   -5.0182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8013   -5.4268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8013   -6.2440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5104   -6.6526    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2194   -6.2440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9285   -6.6526    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.3426   -5.0182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3426   -4.2011    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.0475   -5.4268    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.7566   -5.0182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4657   -5.4268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3426   -6.6526    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.3426   -7.4698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0475   -7.8825    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0475   -8.6997    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3426   -9.1083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6335   -8.6997    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6335   -7.8825    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3426   -9.9255    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.0963   -6.6526    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.0571  -10.3380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1802   -5.0143    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4657   -6.2519    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1802   -6.6644    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8947   -6.2519    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8947   -5.4268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  4  9  1  0
  9 10  1  0
  1 10  1  0
 11 12  2  0
 14 15  1  0
 13 14  1  0
 11 13  1  0
  2 11  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 17 22  1  0
 16 17  1  0
 20 23  1  0
  1 16  2  0
  7 24  1  0
 23 25  1  0
 26 15  2  0
 15 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 26 30  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA2440417

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 400.43

Molecular Weight (Monoisotopic): 400.1423

AlogP: 4.31

#Rotatable Bonds: 5

Polar Surface Area: 84.06

Molecular Species: NEUTRAL

HBA: 5

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 6

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 7.76

CX Basic pKa: 1.45

CX LogP: 4.21

CX LogD: 4.06

Aromatic Rings: 4

Heavy Atoms: 30

QED Weighted: 0.52

Np Likeness Score: -0.80

References

1. Endo S, Hu D, Suyama M, Matsunaga T, Sugimoto K, Matsuya Y, El-Kabbani O, Kuwata K, Hara A, Kitade Y, Toyooka N..  (2013)  Synthesis and structure-activity relationship of 2-phenyliminochromene derivatives as inhibitors for aldo-keto reductase (AKR) 1B10.,  21  (21): [PMID:24071447] [10.1016/j.bmc.2013.08.059]

2. Endo S, Xia S, Suyama M, Morikawa Y, Oguri H, Hu D, Ao Y, Takahara S, Horino Y, Hayakawa Y, Watanabe Y, Gouda H, Hara A, Kuwata K, Toyooka N, Matsunaga T, Ikari A..  (2017)  Synthesis of Potent and Selective Inhibitors of Aldo-Keto Reductase 1B10 and Their Efficacy against Proliferation, Metastasis, and Cisplatin Resistance of Lung Cancer Cells.,  60  (20): [PMID:28976752] [10.1021/acs.jmedchem.7b00830]

Source

Source(1):

• Scientific Literature